Accidentally taking a double dose of tirzepatidea dual GIP and GLP-1 receptor agonist marketed as Mounjaro for type 2 diabetes and Zepbound for weight managementcan amplify the medication's effects and cause concerning symptoms
How do you manage folate in autism
For BPC-157, the mechanistic story is interesting
The best candidates are people who see the medication as a tool for finally getting traction on: Higher protein intake Regular strength training to preserve muscle A sustainable eating pattern they can keep when they are not on medication If youre hoping to take the medication and change nothing else, you will probably lose weight, but you will also likely regain it
Gabrielle Pag, Luda Diatchenko, Qingling Duan, Nader Ghasemlou Clinically, blockade of renal glucose resorption by sodiumglucose cotransporter 2 (SGLT2) inhibitors slows progression of kidney disease, yet the underlying mechanisms are not fully understood